Exact Mass: 297.2303816

Exact Mass Matches: 297.2303816

Found 217 metabolites which its exact mass value is equals to given mass value 297.2303816, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Spiroxamine

8-(1,1-Dimethylethyl)-N-ethyl-N-propyl-1,4-dioxaspiro(4.5)decane-2-methanamine

C18H35NO2 (297.266765)


CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 1800 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2789 CONFIDENCE standard compound; INTERNAL_ID 8403 CONFIDENCE standard compound; INTERNAL_ID 2571 CONFIDENCE standard compound; INTERNAL_ID 4019 D016573 - Agrochemicals D010575 - Pesticides

   

3-oxo-C12 homoserine lactone

N-3-oxo-dodecanoyl-L-homoserine lactone

C16H27NO4 (297.1939982)


CONFIDENCE standard compound; INTERNAL_ID 211

   

3-Ketosphingosine

(2S,4E)-3-ketosphingosine

C18H35NO2 (297.266765)


   

Cassine

(-)-Cassine

C18H35NO2 (297.266765)


   

N-3-oxo-dodecanoyl-L-homoserine lactone

N-3-oxo-dodecanoyl-L-homoserine lactone

C16H27NO4 (297.1939982)


   

Palmitoleoylethanolamde

9-Hexadecenamide, N-(2-hydroxyethyl)-, (9Z)-

C18H35NO2 (297.266765)


Palmitoleoylethanolamde (POEA), belongs to the class of organic compounds known as N-acylethanolamines. N-Acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, palmitoleoylethanolamde is considered to be a fatty amide lipid molecule. Palmitoleoylethanolamde is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. During abstinence, young adults with a history of alcohol binge drinking had elevated plasma levels of monounsaturated and polyunsaturatedacylethanolamides, specifically oleoylethanolamide (OEA), palmitoleoylethanolamide (POEA), arachidonoylethanolamide (AEA), and dihomo-gamma-linolenoylethanolamide (DGLEA). Changes in these lipids positively correlated with mRNA upregulation of inflammatory markers in peripheral blood mononuclear cells (PBMCs), such as toll-like receptors (TLR4), pro-inflammatory cytokines/chemokines, and cyclooxygenase-2 (PMID: 29178411). Palmitoylethanolamide (PEA) is an endogenous fatty acid amide. PEA has been shown to have anti-inflammatory[2] and anti-nociceptive properties. D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

mono-isopropyl-disopyramide

2-phenyl-4-[(propan-2-yl)amino]-2-(pyridin-2-yl)butanimidic acid

C18H23N3O (297.1841028)


mono-isopropyl-disopyramide is a metabolite of disopyramide. Disopyramide (trade names Norpace and Rythmodan) is an antiarrhythmic medication used in the treatment of Ventricular Tachycardia. It is a sodium channel blocker and therefor classified as a Class 1a anti-arrhythmic agent. ’ Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the contractility. Disopyramide also has an anticholinergic effect on the heart which accounts for many adverse side effects. (Wikipedia) D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

Nona-4,6-dienoylcarnitine

3-(nona-4,6-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C16H27NO4 (297.1939982)


Nona-4,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-4,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-4,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-4,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-2,5-dienoylcarnitine

3-(Nona-2,5-dienoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H27NO4 (297.1939982)


Nona-2,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-2,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-2,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-2,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-5,7-dienoylcarnitine

3-(Nona-5,7-dienoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H27NO4 (297.1939982)


Nona-5,7-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-5,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-5,7-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-5,7-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-3,6-dienoylcarnitine

3-(nona-3,6-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C16H27NO4 (297.1939982)


Nona-3,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-3,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-3,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-3,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-4,7-dienoylcarnitine

3-(nona-4,7-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C16H27NO4 (297.1939982)


Nona-4,7-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-4,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-4,7-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-4,7-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-3,5-dienoylcarnitine

3-(nona-3,5-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C16H27NO4 (297.1939982)


Nona-3,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-3,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-3,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-3,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-3,7-dienoylcarnitine

3-(nona-3,7-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C16H27NO4 (297.1939982)


Nona-3,7-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-3,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-3,7-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-3,7-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-2,7-dienoylcarnitine

3-(Nona-2,7-dienoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H27NO4 (297.1939982)


Nona-2,7-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-2,7-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-2,7-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-2,7-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E,6E)-Nona-2,6-dienoylcarnitine

3-(nona-2,6-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C16H27NO4 (297.1939982)


(2E,6E)-nona-2,6-dienoylcarnitine is an acylcarnitine. More specifically, it is an (2E,6E)-nona-2,6-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,6E)-nona-2,6-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,6E)-nona-2,6-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nona-2,4-dienoylcarnitine

3-(Nona-2,4-dienoyloxy)-4-(trimethylazaniumyl)butanoic acid

C16H27NO4 (297.1939982)


Nona-2,4-dienoylcarnitine is an acylcarnitine. More specifically, it is an nona-2,4-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. nona-2,4-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine nona-2,4-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Lauroyl Proline

1-dodecanoylpyrrolidine-2-carboxylic acid

C17H31NO3 (297.2303816)


N-lauroyl proline belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Proline. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Proline is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Proline is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(4E,14Z)-2-Aminooctadeca-4,14-diene-1,3-diol

(4E,14Z)-2-Aminooctadeca-4,14-diene-1,3-diol

C18H35NO2 (297.266765)


   

3-Ketosphingosine

2-amino-1-hydroxyoctadec-4-en-3-one

C18H35NO2 (297.266765)


   

Decadienyl-l-carnitine

3-hydroxy-3-[(trimethylazaniumyl)methyl]trideca-4,6-dienoate

C17H31NO3 (297.2303816)


   

18-hydroxyoleate

18-hydroxyoctadec-9-enoic acid

C18H33O3 (297.2429568)


18-hydroxyoleate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 18-hydroxyoleate can be found in a number of food items such as java plum, red bell pepper, oxheart cabbage, and apricot, which makes 18-hydroxyoleate a potential biomarker for the consumption of these food products.

   
   
   
   
   
   

2-Aminooctadec-4-yne-1,3-diol

2-Aminooctadec-4-yne-1,3-diol

C18H35NO2 (297.266765)


   
   

2-AMINOOCTADECA-4,8-DIENE-1,3-DIOL

2-AMINOOCTADECA-4,8-DIENE-1,3-DIOL

C18H35NO2 (297.266765)


   
   
   
   

(2E,6E,8E)-2,6,8-Hexadecatrien-10-insaeure-(2,3-didehydropyrrolidid)|(2E,6E,8E)-2,6,8-Hexadecatrien-10-insaeure-<2,3-didehydropyrrolidid>

(2E,6E,8E)-2,6,8-Hexadecatrien-10-insaeure-(2,3-didehydropyrrolidid)|(2E,6E,8E)-2,6,8-Hexadecatrien-10-insaeure-<2,3-didehydropyrrolidid>

C20H27NO (297.20925320000003)


   

(6RS,11SR)-(2E,7E,9E)-6,11-dihydroxy-N-(2-hydroxy-2-methylpropyl)-2,7,9-dodecatrienamide|ZP-amide E

(6RS,11SR)-(2E,7E,9E)-6,11-dihydroxy-N-(2-hydroxy-2-methylpropyl)-2,7,9-dodecatrienamide|ZP-amide E

C16H27NO4 (297.1939982)


   

(2E,9Z)-pentadeca-2,9-dien-12,14-diynoic acid piperidine

(2E,9Z)-pentadeca-2,9-dien-12,14-diynoic acid piperidine

C20H27NO (297.20925320000003)


   
   

fasciospyrinadine

fasciospyrinadine

C21H31N (297.2456366)


   

(2E,7Z,12Z)-2,7,12-Hexadecatrien-10-insaeure-(2,3-didehydropyrrolidid)|(2E,7Z,12Z)-2,7,12-Hexadecatrien-10-insaeure-<2,3-didehydropyrrolidid>

(2E,7Z,12Z)-2,7,12-Hexadecatrien-10-insaeure-(2,3-didehydropyrrolidid)|(2E,7Z,12Z)-2,7,12-Hexadecatrien-10-insaeure-<2,3-didehydropyrrolidid>

C20H27NO (297.20925320000003)


   
   

hexadeca-2E, 7Z-dien-10-ynoic acid pyrrolide

hexadeca-2E, 7Z-dien-10-ynoic acid pyrrolide

C20H27NO (297.20925320000003)


   

3-formamido-8-methoxybisabolane-9-en-10-ol

3-formamido-8-methoxybisabolane-9-en-10-ol

C17H31NO3 (297.2303816)


   

N-(2-oxooxolan-3-yl)tridecanamide

N-(2-oxooxolan-3-yl)tridecanamide

C17H31NO3 (297.2303816)


   

C11:db-UHQ aka 2-undecenyl-quinoloin-4(1H)-one position of double bond unknown

C11:db-UHQ aka 2-undecenyl-quinoloin-4(1H)-one position of double bond unknown

C20H27NO (297.20925320000003)


   

UNII:OUT5YHB7BO

Pesticide4_Spiroxamine Isomer 1*_C18H35NO2_N-Ethyl-N-{[8-(2-methyl-2-propanyl)-1,4-dioxaspiro[4.5]dec-2-yl]methyl}-1-propanamine

C18H35NO2 (297.266765)


   

Palmitoleoyl ethanolamide

Palmitoleoyl ethanolamide

C18H35NO2 (297.266765)


An N-acylethanolamine 16:1 that is the ethanolamide of palmitoleic acid. D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials CONFIDENCE standard compound; INTERNAL_ID 27

   

2-(undec-1-en-1-yl)quinolin-4-ol:Series 2 HAQ C11:1

2-(undec-1-en-1-yl)quinolin-4-ol:Series 2 HAQ C11:1

C20H27NO (297.20925320000003)


   

Mono-isopropyl disopyramide

Mono-isopropyl disopyramide

C18H23N3O (297.1841028)


   

N-(3-Oxododecanoyl)-L-homoserine lactone

N-(3-Oxododecanoyl)-L-homoserine lactone

C16H27NO4 (297.1939982)


An N-acyl-L-homoserine lactone having 3-oxododecanoyl as the acyl substituent.

   

UHQ C11:1 aka 2-undecenyl-quinoloin-4(1H)-one position of double bond unknown

UHQ C11:1 aka 2-undecenyl-quinoloin-4(1H)-one position of double bond unknown

C20H27NO (297.20925320000003)


   

Mono-N-desisopropyldisopyramide

Mono-N-desisopropyldisopyramide

C18H23N3O (297.1841028)


   

N-(3-oxododecanoyl) homoserine lactone

N-3-oxo-dodecanoyl-L-homoserine lactone

C16H27NO4 (297.1939982)


   

(Z)-N-(2-hydroxyethyl)hexadec-7-enamide

(Z)-N-(2-hydroxyethyl)hexadec-7-enamide

C18H35NO2 (297.266765)


   
   

N-tridecanoyl-L-Homserine lactone

N-[(3S)-tetrahydro-2-oxo-3-furanyl]-tridecanamide

C17H31NO3 (297.2303816)


   

Palmitoleoyl-EA

N-(9Z-hexadecenoyl)-ethanolamine

C18H35NO2 (297.266765)


   

4E,14Z-Sphingadiene

sphinga-4E,14Z-dienine

C18H35NO2 (297.266765)


   

sphinga-4E,8E-dienine

(4E,8E,d18:2) sphingosine

C18H35NO2 (297.266765)


A sphingoid that is sphingosine having an additional trans-double bond at position 8.

   

sphinga-4E,8Z-dienine

(4E,8Z,d18:2) sphingosine

C18H35NO2 (297.266765)


   

Lepadin D

5S-(5S-hydroxyoctyl)-2S-methyldecahydroquinolin-3R-ol

C18H35NO2 (297.266765)


   

2S-amino-octadeca-4E,6E-diene-1,3R-diol

2S-amino-octadeca-4E,6E-diene-1,3R-diol

C18H35NO2 (297.266765)


   

Dinor-7-NO2-CLA

7-nitro-7Z,9E-hexadecadienoic acid

C16H27NO4 (297.1939982)


   

Dinor-10-NO2-CLA

10-nitro-7E,9Z-hexadecadienoic acid

C16H27NO4 (297.1939982)


   

NAE 16:1

N-(9Z-hexadecenoyl)-ethanolamine

C18H35NO2 (297.266765)


   

SPB 18:2;O2

(4E,8Z,d18:2) sphingosine

C18H35NO2 (297.266765)


   

sphingadiene

(4E,8E,d18:2) sphingosine

C18H35NO2 (297.266765)


   

ammonium tridecan-1-yl sulphate

ammonium tridecan-1-yl sulphate

C13H31NO4S (297.1973686)


   

1-BOC-4-METHYL-4-(4-METHYLPIPERAZIN-1-YL)PIPERIDINE

1-BOC-4-METHYL-4-(4-METHYLPIPERAZIN-1-YL)PIPERIDINE

C16H31N3O2 (297.2416146)


   

1-TERT-BUTYL 4-ETHYL 4-ALLYLPIPERIDINE-1,4-DICARBOXYLATE

1-TERT-BUTYL 4-ETHYL 4-ALLYLPIPERIDINE-1,4-DICARBOXYLATE

C16H27NO4 (297.1939982)


   

1,3-Piperidinedicarboxylic acid, 3-(2-propen-1-yl)-, 1-(1,1-dimethylethyl) 3-ethyl ester

1,3-Piperidinedicarboxylic acid, 3-(2-propen-1-yl)-, 1-(1,1-dimethylethyl) 3-ethyl ester

C16H27NO4 (297.1939982)


   

(S)-(+)-2-(N,N-DIBENZYLAMINO)-4-METHYLPENTANOL, 90

(S)-(+)-2-(N,N-DIBENZYLAMINO)-4-METHYLPENTANOL, 90

C20H27NO (297.20925320000003)


   

3-[(tert-butoxy)carbonyl]-3-azaspiro[5.5]undecane-9-carboxylic acid

3-[(tert-butoxy)carbonyl]-3-azaspiro[5.5]undecane-9-carboxylic acid

C16H27NO4 (297.1939982)


   
   

(S)-2-(4-TRIFLUOROMETHYLPHENYLAMINO)PROPAN-1-OL

(S)-2-(4-TRIFLUOROMETHYLPHENYLAMINO)PROPAN-1-OL

C20H27NO (297.20925320000003)


   

Tranexamic Acid Dimer

Tranexamic Acid Dimer

C16H27NO4 (297.1939982)


   

Atolide

2-amino-N-[4-(diethylamino)-2-methylphenyl]benzamide

C18H23N3O (297.1841028)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

   
   

1-BOC-3-[(PIPERIDIN-1-YLETHYL)-AMINO]-PYRROLIDINE

1-BOC-3-[(PIPERIDIN-1-YLETHYL)-AMINO]-PYRROLIDINE

C16H31N3O2 (297.2416146)


   

4-[(4-ethoxyphenyl)azo]-N,N-diethylaniline

4-[(4-ethoxyphenyl)azo]-N,N-diethylaniline

C18H23N3O (297.1841028)


   

(2RS)-2-Cyclohexyl-2-(4-Methoxyphenyl)-N,NdimethylethanamineHydrochloride

(2RS)-2-Cyclohexyl-2-(4-Methoxyphenyl)-N,NdimethylethanamineHydrochloride

C17H28ClNO (297.18593080000005)


   

5-(dibenzylamino)-2-methylpentan-2-ol

5-(dibenzylamino)-2-methylpentan-2-ol

C20H27NO (297.20925320000003)


   
   

4-FLUORO-3-FORMYLBENZENEBORONICACID

4-FLUORO-3-FORMYLBENZENEBORONICACID

C16H27NO4 (297.1939982)


   

4-(Hexahydro-5-oxo-1H-1,4-diazepin-1-yl)-1-piperidinecarboxylic acid tert-butyl ester

4-(Hexahydro-5-oxo-1H-1,4-diazepin-1-yl)-1-piperidinecarboxylic acid tert-butyl ester

C15H27N3O3 (297.20523119999996)


   

4-Piperidinecarbonitrile,4-(cyclohexylamino)-1-(phenylmethyl)-

4-Piperidinecarbonitrile,4-(cyclohexylamino)-1-(phenylmethyl)-

C19H27N3 (297.2204862)


   

tert-butyl (1-(piperidin-4-yl)piperidin-4-yl)Methylcarbamate

tert-butyl (1-(piperidin-4-yl)piperidin-4-yl)Methylcarbamate

C16H31N3O2 (297.2416146)


   

2-Methyl-2-propanyl 3-ethyl-3-methyl-1-oxo-2-oxa-7-azaspiro[4.5]d ecane-7-carboxylate

2-Methyl-2-propanyl 3-ethyl-3-methyl-1-oxo-2-oxa-7-azaspiro[4.5]d ecane-7-carboxylate

C16H27NO4 (297.1939982)


   

N-Dodecanoyl-proline

N-Dodecanoyl-L-proline

C17H31NO3 (297.2303816)


   

4-tert-butyl-2-(diethylaminomethyl)-3-dimethylsilyloxycyclopent-2-en-1-one

4-tert-butyl-2-(diethylaminomethyl)-3-dimethylsilyloxycyclopent-2-en-1-one

C16H31NO2Si (297.2123946)


   

1-dodecyl-5-oxopyrrolidine-3-carboxylic acid

1-dodecyl-5-oxopyrrolidine-3-carboxylic acid

C17H31NO3 (297.2303816)


   

2-(4-amino-3-pyridyl)-N,N-diisopropyl-benzamide

2-(4-amino-3-pyridyl)-N,N-diisopropyl-benzamide

C18H23N3O (297.1841028)


   

1-(3,3-Diphenyl-N-methylpropylamino)-2-methyl-2-propanol

1-(3,3-Diphenyl-N-methylpropylamino)-2-methyl-2-propanol

C20H27NO (297.20925320000003)


   

1-(Isopropylamino)-3-{4-[(2-methoxyethoxy)methyl]phenoxy}-2-propanol

1-(Isopropylamino)-3-{4-[(2-methoxyethoxy)methyl]phenoxy}-2-propanol

C16H27NO4 (297.1939982)


   

Benzenemethanamine, α-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-α-ethenyl-, (αS)-

Benzenemethanamine, α-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-α-ethenyl-, (αS)-

C18H23N3O (297.1841028)


   

(1-Methyl-4-piperidinyl)[1-(2-phenylethyl)-1H-imidazol-2-yl]methanone

(1-Methyl-4-piperidinyl)[1-(2-phenylethyl)-1H-imidazol-2-yl]methanone

C18H23N3O (297.1841028)


   

2-Azaspiro[5.5]undecan-2,9-dicarboxylic acid 2-tert-butyl ester

2-Azaspiro[5.5]undecan-2,9-dicarboxylic acid 2-tert-butyl ester

C16H27NO4 (297.1939982)


   

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-amine

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-amine

C18H24BNO2 (297.1899994)


   

4-(PIPERIDINE-4-CARBONYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(PIPERIDINE-4-CARBONYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H27N3O3 (297.20523119999996)


   

1-(2,3-dimethyl-1H-indol-1-yl)-3-(3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol

1-(2,3-dimethyl-1H-indol-1-yl)-3-(3,5-dimethyl-1H-pyrazol-1-yl)propan-2-ol

C18H23N3O (297.1841028)


   

N-[2-(1-phenyl-1H-pyrazol-3-yl)ethyl]cyclohexanecarboxamide

N-[2-(1-phenyl-1H-pyrazol-3-yl)ethyl]cyclohexanecarboxamide

C18H23N3O (297.1841028)


   

4-Spiro-(N-methylpiperidyl)-2,2,9-trimethyl-1,2,3,4-tetrahydro-gamma-carboline

4-Spiro-(N-methylpiperidyl)-2,2,9-trimethyl-1,2,3,4-tetrahydro-gamma-carboline

C19H27N3 (297.2204862)


   
   

Ricinoleate

Ricinoleate

C18H33O3- (297.2429568)


A hydroxy fatty acid anion that is the conjugate base of ricinoleic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Pristanate

Pristanate

C19H37O2- (297.2793402)


A methyl-branched fatty acid anion that is the conjugate base of pristanic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

18-hydroxyoleate

18-hydroxyoleate

C18H33O3- (297.2429568)


An omega-hydroxy fatty acid anion that is the conjugate base of 18-hydroxyoleic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Nonadecanoate

Nonadecanoate

C19H37O2- (297.2793402)


A nineteen carbon straight-chain fatty acid anion. Major species at pH 7.3.

   
   
   

17-Methyloctadecanoate

17-Methyloctadecanoate

C19H37O2- (297.2793402)


   

10-Methyloctadecanoate

10-Methyloctadecanoate

C19H37O2- (297.2793402)


   

(8E,10S)-10-hydroxyoctadec-8-enoate

(8E,10S)-10-hydroxyoctadec-8-enoate

C18H33O3- (297.2429568)


   

(9E)-17-hydroxy-octadec-9-enoate

(9E)-17-hydroxy-octadec-9-enoate

C18H33O3- (297.2429568)


   

(2s,3r,4e)-2-Amino-1,3-dihydroxy octadeca-4,8-diene

(2s,3r,4e)-2-Amino-1,3-dihydroxy octadeca-4,8-diene

C18H35NO2 (297.266765)


   

(E)-18-hydroxyoctadec-9-enoate

(E)-18-hydroxyoctadec-9-enoate

C18H33O3- (297.2429568)


   

(4E,6E)-3-hydroxy-3-[(trimethylazaniumyl)methyl]trideca-4,6-dienoate

(4E,6E)-3-hydroxy-3-[(trimethylazaniumyl)methyl]trideca-4,6-dienoate

C17H31NO3 (297.2303816)


   

Nona-4,6-dienoylcarnitine

Nona-4,6-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-2,5-dienoylcarnitine

Nona-2,5-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-5,7-dienoylcarnitine

Nona-5,7-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-3,6-dienoylcarnitine

Nona-3,6-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-4,7-dienoylcarnitine

Nona-4,7-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-3,5-dienoylcarnitine

Nona-3,5-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-3,7-dienoylcarnitine

Nona-3,7-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-2,7-dienoylcarnitine

Nona-2,7-dienoylcarnitine

C16H27NO4 (297.1939982)


   

Nona-2,4-dienoylcarnitine

Nona-2,4-dienoylcarnitine

C16H27NO4 (297.1939982)


   

(2E,6E)-Nona-2,6-dienoylcarnitine

(2E,6E)-Nona-2,6-dienoylcarnitine

C16H27NO4 (297.1939982)


   

(E)-2-amino-1-hydroxyoctadec-4-en-3-one

(E)-2-amino-1-hydroxyoctadec-4-en-3-one

C18H35NO2 (297.266765)


   

(9Z)-12-Hydroxyoctadec-9-enoate

(9Z)-12-Hydroxyoctadec-9-enoate

C18H33O3- (297.2429568)


A hydroxy fatty acid anion that is the conjugate base of (9Z)-12-hydroxyoctadec-9-enoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

2-Methyloctadecanoate

2-Methyloctadecanoate

C19H37O2- (297.2793402)


   

N-(3-oxododecanoyl)-D-homoserine lactone

N-(3-oxododecanoyl)-D-homoserine lactone

C16H27NO4 (297.1939982)


   

12-Methyloctadecanoate

12-Methyloctadecanoate

C19H37O2- (297.2793402)


A methyl-branched fatty acid anion that is the conjugate base of 12-methyloctadecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

1-(1-Naphthalenyl)-3-[3-(1-pyrrolidinyl)propyl]urea

1-(1-Naphthalenyl)-3-[3-(1-pyrrolidinyl)propyl]urea

C18H23N3O (297.1841028)


   

(1S,3S,3aR,6S,6aR,9aS,9bS)-6-isocyano-3,6-dimethyl-9-methylidene-1-(2-methylprop-2-enyl)-2,3,3a,4,5,6a,7,8,9a,9b-decahydro-1H-phenalene

(1S,3S,3aR,6S,6aR,9aS,9bS)-6-isocyano-3,6-dimethyl-9-methylidene-1-(2-methylprop-2-enyl)-2,3,3a,4,5,6a,7,8,9a,9b-decahydro-1H-phenalene

C21H31N (297.2456366)


A natural product found in Pseudaxinella flava.

   

(1S,3S,3aR,6S,6aR,9aS,9bS)-6-isocyano-3,6-dimethyl-9-methylidene-1-(2-methylprop-1-enyl)-2,3,3a,4,5,6a,7,8,9a,9b-decahydro-1H-phenalene

(1S,3S,3aR,6S,6aR,9aS,9bS)-6-isocyano-3,6-dimethyl-9-methylidene-1-(2-methylprop-1-enyl)-2,3,3a,4,5,6a,7,8,9a,9b-decahydro-1H-phenalene

C21H31N (297.2456366)


A natural product found in Pseudaxinella flava.

   

(9E)-12-hydroxyoctadec-9-enoate

(9E)-12-hydroxyoctadec-9-enoate

C18H33O3- (297.2429568)


A hydroxy fatty acid anion that is the conjugate base of (9E)-12-hydroxyoctadec-9-enoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

2-(4,5,6,7-tetrahydroindazol-2-yl)-N-(2,4,6-trimethylphenyl)acetamide

2-(4,5,6,7-tetrahydroindazol-2-yl)-N-(2,4,6-trimethylphenyl)acetamide

C18H23N3O (297.1841028)


   

(9R,10S)-9,10-epoxyoctadecanoate

(9R,10S)-9,10-epoxyoctadecanoate

C18H33O3- (297.2429568)


A 9,10-epoxyoctadecanoate that is the conjugate base of (9R,10S)-9,10-epoxyoctadecanoic acid arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   
   

10-Oxooctadecanoate

10-Oxooctadecanoate

C18H33O3- (297.2429568)


   

cis-9,10-Epoxyoctadecanoate

cis-9,10-Epoxyoctadecanoate

C18H33O3- (297.2429568)


   

1-[(2-Methoxyphenyl)methyl]-4-(3-pyridinylmethyl)piperazine

1-[(2-Methoxyphenyl)methyl]-4-(3-pyridinylmethyl)piperazine

C18H23N3O (297.1841028)


   

(12Z)-10-hydroxyoctadecenoate

(12Z)-10-hydroxyoctadecenoate

C18H33O3- (297.2429568)


   
   
   

Noribogaine(1+)

Noribogaine(1+)

C19H25N2O+ (297.196678)


A tertiary ammonium ion resulting from the protonation of the tertiary amino group of noribogaine.

   
   

(10S)-hydroxy-(12Z)-octadecenoate

(10S)-hydroxy-(12Z)-octadecenoate

C18H33O3- (297.2429568)


   

10-hydroxy-(11E)-octadecenoate

10-hydroxy-(11E)-octadecenoate

C18H33O3- (297.2429568)


   

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]pentanamide

C17H31NO3 (297.2303816)


   

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]propanamide

C17H31NO3 (297.2303816)


   

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]butanamide

C17H31NO3 (297.2303816)


   

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]acetamide

C17H31NO3 (297.2303816)


   

3,3,5-Trimethyl-1,2,3,4-tetrahydro-gamma-carboline-1-spiro-4-(1-methyl)piperidine(2-D)

3,3,5-Trimethyl-1,2,3,4-tetrahydro-gamma-carboline-1-spiro-4-(1-methyl)piperidine(2-D)

C19H27N3 (297.2204862)


   

(8E,10S)-10-hydroxy-8-octadecenoate

(8E,10S)-10-hydroxy-8-octadecenoate

C18H33O3 (297.2429568)


An unsaturated fatty acid anion that is the conjugate base of (8E,10S)-10-hydroxy-8-octadecenoic acid, obtained by deprotonation of the carboxy group.

   

Spiroxamine

UNII:OUT5YHB7BO

C18H35NO2 (297.266765)


D016573 - Agrochemicals D010575 - Pesticides

   

4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide

4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide

C18H23N3O (297.1841028)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

N-(3-Oxododecanoyl)homoserine lactone

N-(3-Oxododecanoyl)homoserine lactone

C16H27NO4 (297.1939982)


   

sphinga-4E,14Z-dienine

sphinga-4E,14Z-dienine

C18H35NO2 (297.266765)


A sphingoid that is sphingosine having an additional cis-double bond at position 14.

   

(9S,10R)-epoxyoctadecanoate

(9S,10R)-epoxyoctadecanoate

C18H33O3 (297.2429568)


A 9,10-epoxyoctadecanoate that is the conjugate base of (9S,10R)-epoxyoctadecanoic acid arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

(12Z)-10-hydroxyoctadec-12-enoate

(12Z)-10-hydroxyoctadec-12-enoate

C18H33O3 (297.2429568)


A hydroxy monounsaturated fatty acid anion that is the conjugate base of (12Z)-10-hydroxyoctadec-12-enoic acid, resulting from the deprotonation of the carboxy group; major species at pH 7.3.

   

all-trans-3,4-didehydroretinoate(1-)

all-trans-3,4-didehydroretinoate(1-)

C20H25O2 (297.18544499999996)


A monocarboxylic acid anion derived from 3,4-desaturation of beta-ionone ring of all-trans-retinoate; major species at pH 7.3.

   

2-hydroxyoctadecenoate

2-hydroxyoctadecenoate

C18H33O3 (297.2429568)


A 2-hydroxy fatty acid anion with a chain that is composed of 18 carbons and 1 double bond (position unspecified).

   

fatty acid anion 19:0

fatty acid anion 19:0

C19H37O2 (297.2793402)


A fatty acid anion containing 19 carbons and 0 double bonds. Major species at pH 7.3.

   

9,10-Epoxyoctadecanoate

9,10-Epoxyoctadecanoate

C18H33O3 (297.2429568)


An epoxystearate resulting from the deprotonation of the carboxy group of 9,10-epoxyoctadecanoic acid (i.e. conjugate base of 9,10-epoxyoctadecanoic acid); the major species at pH 7.3.

   

Sphingosine (d18:2)

SPH(d18:2)

C18H35NO2 (297.266765)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   

(2e,6z,8e,10r,11s)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

(2e,6z,8e,10r,11s)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

C16H27NO4 (297.1939982)


   

2-(undec-1-en-1-yl)-1h-quinolin-4-one

2-(undec-1-en-1-yl)-1h-quinolin-4-one

C20H27NO (297.20925320000003)


   

2-[(4z)-undec-4-en-1-yl]-1h-quinolin-4-one

2-[(4z)-undec-4-en-1-yl]-1h-quinolin-4-one

C20H27NO (297.20925320000003)


   

(2s,4e)-5-hydroxy-4-(1-hydroxydecylidene)-2-(2-hydroxyethyl)-2h-pyrrol-3-one

(2s,4e)-5-hydroxy-4-(1-hydroxydecylidene)-2-(2-hydroxyethyl)-2h-pyrrol-3-one

C16H27NO4 (297.1939982)


   

(7as)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2r,3s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylpentanoate

(7as)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2r,3s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylpentanoate

C16H27NO4 (297.1939982)


   

(5s)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(5s)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

(7as)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

(7as)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1r)-1-methoxyethyl]-3-methylbutanoate

C16H27NO4 (297.1939982)


   

1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7,12-trien-10-yn-1-one

1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7,12-trien-10-yn-1-one

C20H27NO (297.20925320000003)


   

(2e,9e)-1-(piperidin-1-yl)pentadeca-2,9-dien-12,14-diyn-1-one

(2e,9e)-1-(piperidin-1-yl)pentadeca-2,9-dien-12,14-diyn-1-one

C20H27NO (297.20925320000003)


   

11-(5-hydroxy-6-methylpiperidin-2-yl)-3-methylundecan-2-one

11-(5-hydroxy-6-methylpiperidin-2-yl)-3-methylundecan-2-one

C18H35NO2 (297.266765)


   

(3s)-11-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]-3-methylundecan-2-one

(3s)-11-[(2r,5s,6s)-5-hydroxy-6-methylpiperidin-2-yl]-3-methylundecan-2-one

C18H35NO2 (297.266765)


   

(2e,4e)-n-(2-methylpropyl)hexadeca-2,4,9-trien-12,14-diynimidic acid

(2e,4e)-n-(2-methylpropyl)hexadeca-2,4,9-trien-12,14-diynimidic acid

C20H27NO (297.20925320000003)


   

(2e,7z,12z)-1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7,12-trien-10-yn-1-one

(2e,7z,12z)-1-(2,3-dihydropyrrol-1-yl)hexadeca-2,7,12-trien-10-yn-1-one

C20H27NO (297.20925320000003)


   

12-(5-hydroxy-6-methylpiperidin-2-yl)dodecan-2-one

12-(5-hydroxy-6-methylpiperidin-2-yl)dodecan-2-one

C18H35NO2 (297.266765)


   

(3z,5r)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(3z,5r)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

(2s,3r,4as,5s,8ar)-5-[(5r)-5-hydroxyoctyl]-2-methyl-decahydroquinolin-3-ol

(2s,3r,4as,5s,8ar)-5-[(5r)-5-hydroxyoctyl]-2-methyl-decahydroquinolin-3-ol

C18H35NO2 (297.266765)


   

(2e,6r,7e,9e,11r)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

(2e,6r,7e,9e,11r)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO4 (297.1939982)


   

(5r)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(5r)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO4 (297.1939982)


   

(2e,4e,9z)-n-(2-methylpropyl)hexadeca-2,4,9-trien-12,14-diynimidic acid

(2e,4e,9z)-n-(2-methylpropyl)hexadeca-2,4,9-trien-12,14-diynimidic acid

C20H27NO (297.20925320000003)


   

(7as)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2s,3s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylpentanoate

(7as)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl (2s,3s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylpentanoate

C16H27NO4 (297.1939982)


   

(3z,5s)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(3z,5s)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1s)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

(2e,6e,8e)-1-(2,3-dihydropyrrol-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

(2e,6e,8e)-1-(2,3-dihydropyrrol-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

C20H27NO (297.20925320000003)


   

5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl 2-hydroxy-2-isopropyl-3-methoxybutanoate

5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl 2-hydroxy-2-isopropyl-3-methoxybutanoate

C16H27NO4 (297.1939982)


   

1-(pyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

1-(pyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

C20H27NO (297.20925320000003)


   

10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

C16H27NO4 (297.1939982)


   

2-(undec-4-en-1-yl)-1h-quinolin-4-one

2-(undec-4-en-1-yl)-1h-quinolin-4-one

C20H27NO (297.20925320000003)


   

(2r,4e)-5-hydroxy-4-(1-hydroxydecylidene)-2-(2-hydroxyethyl)-2h-pyrrol-3-one

(2r,4e)-5-hydroxy-4-(1-hydroxydecylidene)-2-(2-hydroxyethyl)-2h-pyrrol-3-one

C16H27NO4 (297.1939982)


   

(3z,5s)-3-(1-hydroxy-2-methyloctylidene)-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

(3z,5s)-3-(1-hydroxy-2-methyloctylidene)-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

2-[(1e)-undec-1-en-1-yl]-1h-quinolin-4-one

2-[(1e)-undec-1-en-1-yl]-1h-quinolin-4-one

C20H27NO (297.20925320000003)


   

3-(1-hydroxy-2-methyloctylidene)-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

3-(1-hydroxy-2-methyloctylidene)-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

(2e,6s,7e,9e,11r)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

(2e,6s,7e,9e,11r)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO4 (297.1939982)


   

(2e,7z)-1-(pyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

(2e,7z)-1-(pyrrol-1-yl)hexadeca-2,7-dien-10-yn-1-one

C20H27NO (297.20925320000003)


   

(3z,5s)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1r)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

(3z,5s)-3-[(2r)-1-hydroxy-2-methyloctylidene]-5-[(1r)-1-hydroxyethyl]-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

2-[(3z)-undec-3-en-1-yl]-1h-quinolin-4-one

2-[(3z)-undec-3-en-1-yl]-1h-quinolin-4-one

C20H27NO (297.20925320000003)


   

(2e,6z,8e)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

(2e,6z,8e)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

C16H27NO4 (297.1939982)


   

3-oxo-n-[(3s)-2-oxooxolan-3-yl]dodecanimidic acid

3-oxo-n-[(3s)-2-oxooxolan-3-yl]dodecanimidic acid

C16H27NO4 (297.1939982)


   

1-(piperidin-1-yl)pentadeca-2,9-dien-12,14-diyn-1-one

1-(piperidin-1-yl)pentadeca-2,9-dien-12,14-diyn-1-one

C20H27NO (297.20925320000003)


   

(2e,7e,9e)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

(2e,7e,9e)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO4 (297.1939982)


   

1-(2,3-dihydropyrrol-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

1-(2,3-dihydropyrrol-1-yl)hexadeca-2,6,8-trien-10-yn-1-one

C20H27NO (297.20925320000003)


   

16-ethyl-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

16-ethyl-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

[C19H25N2O]+ (297.196678)


   

(2e,6e,8e)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

(2e,6e,8e)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

C16H27NO4 (297.1939982)


   

(3z,5r)-3-(1-hydroxy-2-methyloctylidene)-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

(3z,5r)-3-(1-hydroxy-2-methyloctylidene)-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C16H27NO4 (297.1939982)


   

(2e,6z,8e,10r,11r)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

(2e,6z,8e,10r,11r)-10,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,6,8-trienimidic acid

C16H27NO4 (297.1939982)


   

(2r,3s,4ar,5r,8as)-5-(5-hydroxyoctyl)-2-methyl-decahydroquinolin-3-ol

(2r,3s,4ar,5r,8as)-5-(5-hydroxyoctyl)-2-methyl-decahydroquinolin-3-ol

C18H35NO2 (297.266765)


   

5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl 2-hydroxy-2-(1-hydroxyethyl)-3-methylpentanoate

5,6,7,7a-tetrahydro-3h-pyrrolizin-1-ylmethyl 2-hydroxy-2-(1-hydroxyethyl)-3-methylpentanoate

C16H27NO4 (297.1939982)


   

(2e,6s,7e,9e,11s)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

(2e,6s,7e,9e,11s)-6,11-dihydroxy-n-(2-hydroxy-2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO4 (297.1939982)